Inspire Medical Systems (INSP) Depreciation & Amortization (CF) (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 67.87% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $16.0 million (up 83.02% YoY), and the FY2025 full-year result was $14.0 million, up 113.08% from the prior year.
• Depreciation & Amortization (CF) improved to $5.1 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.1 million in Q1 2026 to a low of $359000.0 in Q1 2022.
• A 5-year average of $1.8 million and a median of $839000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) soared 37.17% in 2022 and jumped 262.81% in 2025, its largest moves.
• Tracing INSP's Depreciation & Amortization (CF) over 5 years: stood at $569000.0 in 2022, then soared by 43.59% to $817000.0 in 2023, then surged by 203.3% to $2.5 million in 2024, then soared by 54.24% to $3.8 million in 2025, then soared by 33.7% to $5.1 million in 2026.
• Business Quant data shows INSP's Depreciation & Amortization (CF) at $5.1 million in Q1 2026, $3.8 million in Q4 2025, and $3.7 million in Q3 2025.